Medicare Dialysis Drug Payments Should Be Based On ASP, MedPAC Says
Executive Summary
Medicare reimbursement for all injectable drugs used in dialysis facilities should be average sales price plus 6%, the Medicare Payment Advisory Commission's June report to Congress says